Global Biochips Market Overview And Scope:
Global Biochips Market Size was estimated at USD 10387.18 million in 2022 and is projected to reach USD 17604.29 million by 2028, exhibiting a CAGR of 9.19% during the forecast period.
The Global Biochips Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Biochips utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Abbott, Agilent Technologies, Illumina, PerkinElmer, Thermo Fisher Scientific, BioChain, Bio-Rad Laboratories, Cepheid, EMD Millipore, Fluidigm, SuperBioChips Laboratories, US Biomax, Roche Diagnostics
Global Biochips Market Segmentation
By Type, Biochips market has been segmented into:DNA Chip
Lab-on-a-Chip
Protein Chip
Others
By Application, Biochips market has been segmented into:
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic and Research Institutes
Other End Users
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biochips market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biochips market.
Top Key Players Covered in Biochips market are:
Abbott
Agilent Technologies
Illumina
PerkinElmer
Thermo Fisher Scientific
BioChain
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax
Roche Diagnostics
Objective to buy this Report:
1. Biochips analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biochips market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Biochips Market by Type
5.1 Biochips Market Overview Snapshot and Growth Engine
5.2 Biochips Market Overview
5.3 DNA Chip
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 DNA Chip: Geographic Segmentation
5.4 Lab-on-a-Chip
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Lab-on-a-Chip: Geographic Segmentation
5.5 Protein Chip
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Protein Chip: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Biochips Market by Application
6.1 Biochips Market Overview Snapshot and Growth Engine
6.2 Biochips Market Overview
6.3 Biotechnology and Pharmaceutical Companies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Biotechnology and Pharmaceutical Companies: Geographic Segmentation
6.4 Hospitals and Diagnostics Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals and Diagnostics Centers: Geographic Segmentation
6.5 Academic and Research Institutes
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Academic and Research Institutes: Geographic Segmentation
6.6 Other End Users
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other End Users: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biochips Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biochips Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biochips Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 AGILENT TECHNOLOGIES
7.4 ILLUMINA
7.5 PERKINELMER
7.6 THERMO FISHER SCIENTIFIC
7.7 BIOCHAIN
7.8 BIO-RAD LABORATORIES
7.9 CEPHEID
7.10 EMD MILLIPORE
7.11 FLUIDIGM
7.12 SUPERBIOCHIPS LABORATORIES
7.13 US BIOMAX
7.14 ROCHE DIAGNOSTICS
Chapter 8: Global Biochips Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 DNA Chip
8.2.2 Lab-on-a-Chip
8.2.3 Protein Chip
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Biotechnology and Pharmaceutical Companies
8.3.2 Hospitals and Diagnostics Centers
8.3.3 Academic and Research Institutes
8.3.4 Other End Users
Chapter 9: North America Biochips Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 DNA Chip
9.4.2 Lab-on-a-Chip
9.4.3 Protein Chip
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Biotechnology and Pharmaceutical Companies
9.5.2 Hospitals and Diagnostics Centers
9.5.3 Academic and Research Institutes
9.5.4 Other End Users
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Biochips Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 DNA Chip
10.4.2 Lab-on-a-Chip
10.4.3 Protein Chip
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Biotechnology and Pharmaceutical Companies
10.5.2 Hospitals and Diagnostics Centers
10.5.3 Academic and Research Institutes
10.5.4 Other End Users
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Biochips Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 DNA Chip
11.4.2 Lab-on-a-Chip
11.4.3 Protein Chip
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Biotechnology and Pharmaceutical Companies
11.5.2 Hospitals and Diagnostics Centers
11.5.3 Academic and Research Institutes
11.5.4 Other End Users
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Biochips Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 DNA Chip
12.4.2 Lab-on-a-Chip
12.4.3 Protein Chip
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Biotechnology and Pharmaceutical Companies
12.5.2 Hospitals and Diagnostics Centers
12.5.3 Academic and Research Institutes
12.5.4 Other End Users
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Biochips Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 DNA Chip
13.4.2 Lab-on-a-Chip
13.4.3 Protein Chip
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Biotechnology and Pharmaceutical Companies
13.5.2 Hospitals and Diagnostics Centers
13.5.3 Academic and Research Institutes
13.5.4 Other End Users
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Biochips Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 DNA Chip
14.4.2 Lab-on-a-Chip
14.4.3 Protein Chip
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Biotechnology and Pharmaceutical Companies
14.5.2 Hospitals and Diagnostics Centers
14.5.3 Academic and Research Institutes
14.5.4 Other End Users
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Biochips Scope:
|
Report Data
|
Biochips Market
|
|
Biochips Market Size in 2022
|
USD 10387.18 million
|
|
Biochips CAGR 2023 - 2030
|
9.19%
|
|
Biochips Base Year
|
2022
|
|
Biochips Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, Agilent Technologies, Illumina, PerkinElmer, Thermo Fisher Scientific, BioChain, Bio-Rad Laboratories, Cepheid, EMD Millipore, Fluidigm, SuperBioChips Laboratories, US Biomax, Roche Diagnostics.
|
|
Key Segments
|
By Type
DNA Chip
Lab-on-a-Chip
Protein Chip
Others
By Applications
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic and Research Institutes
Other End Users
|
